Metropolitan Life Insurance Company (MetLife)’s CATALENT, INC. CTLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,289
| Closed | -$411K | – | 2231 |
|
|
2024
Q1 | $411K | Sell |
7,289
-48
| -0.7% | -$2.6K | 0.02% | 506 |
|
|
2023
Q4 | $330K | Sell |
7,337
-120
| -2% | -$4.85K | 0.02% | 554 |
|
|
2023
Q3 | $340K | Sell |
7,457
-390
| -5% | -$18.2K | 0.02% | 523 |
|
|
2023
Q2 | $340K | Sell |
7,847
-207
| -3% | -$9.09K | 0.02% | 524 |
|
|
2023
Q1 | $529K | Sell |
8,054
-2,352
| -23% | -$145K | 0.03% | 447 |
|
|
2022
Q4 | $468K | Sell |
10,406
-34
| -0.3% | -$1.85K | 0.02% | 500 |
|
|
2022
Q3 | $755K | Sell |
10,440
-126
| -1% | -$12.5K | 0.04% | 412 |
|
|
2022
Q2 | $1.13M | Sell |
10,566
-261
| -2% | -$26.6K | 0.05% | 339 |
|
|
2022
Q1 | $1.2M | Sell |
10,827
-10,364
| -49% | -$1.08M | 0.04% | 366 |
|
|
2021
Q4 | $2.71M | Sell |
21,191
-111
| -0.5% | -$14.3K | 0.04% | 397 |
|
|
2021
Q3 | $2.83M | Sell |
21,302
-727
| -3% | -$90.8K | 0.04% | 362 |
|
|
2021
Q2 | $2.38M | Buy |
22,029
+1,585
| +8% | +$170K | 0.03% | 441 |
|
|
2021
Q1 | $2.15M | Sell |
20,444
-438
| -2% | -$48.9K | 0.03% | 485 |
|
|
2020
Q4 | $2.17M | Sell |
20,882
-986
| -5% | -$95.6K | 0.03% | 443 |
|
|
2020
Q3 | $1.87M | Sell |
21,868
-9,481
| -30% | -$802K | 0.03% | 437 |
|
|
2020
Q2 | $2.3M | Sell |
31,349
-9,830
| -24% | -$667K | 0.04% | 365 |
|
|
2020
Q1 | $2.14M | Buy |
41,179
+134
| +0.3% | +$7.32K | 0.04% | 355 |
|
|
2019
Q4 | $2.31M | Buy |
41,045
+321
| +0.8% | +$16.4K | 0.04% | 464 |
|
|
2019
Q3 | $1.94M | Sell |
40,724
-2,566
| -6% | -$138K | 0.03% | 518 |
|
|
2019
Q2 | $2.35M | Sell |
43,290
-25
| -0.1% | -$1.15K | 0.04% | 441 |
|
|
2019
Q1 | $1.76M | Sell |
43,315
-38
| -0.1% | -$1.49K | 0.03% | 553 |
|
|
2018
Q4 | $1.35M | Buy |
43,353
+244
| +0.6% | +$9.41K | 0.03% | 633 |
|
|
2018
Q3 | $1.96M | Buy |
43,109
+3,054
| +8% | +$129K | 0.03% | 542 |
|
|
2018
Q2 | $1.68M | Sell |
40,055
-37,188
| -48% | -$1.5M | 0.03% | 623 |
|
|
2018
Q1 | $3.17M | Buy |
77,243
+1,485
| +2% | +$63.2K | 0.04% | 312 |
|
|
2017
Q4 | $3.11M | Sell |
75,758
-332,726
| -81% | -$13.5M | 0.04% | 321 |
|
|
2017
Q3 | $16.3M | Buy |
408,484
+209,270
| +105% | +$7.75M | 0.1% | 173 |
|
|
2017
Q2 | $6.99M | Buy |
199,214
+17,101
| +9% | +$562K | 0.05% | 375 |
|
|
2017
Q1 | $5.16M | Sell |
182,113
-1,912
| -1% | -$53.5K | 0.04% | 572 |
|
|
2016
Q4 | $4.96M | Sell |
184,025
-1,512
| -0.8% | -$37.5K | 0.04% | 578 |
|
|
2016
Q3 | $4.79M | Buy |
185,537
+15,814
| +9% | +$393K | 0.04% | 566 |
|
|
2016
Q2 | $3.9M | Buy |
169,723
+21,392
| +14% | +$564K | 0.03% | 655 |
|
|
2016
Q1 | $3.96M | Buy |
148,331
+5,743
| +4% | +$140K | 0.03% | 624 |
|
|
2015
Q4 | $3.57M | Buy |
142,588
+359
| +0.3% | +$9.47K | 0.03% | 651 |
|
|
2015
Q3 | $3.46M | Buy |
142,229
+83,900
| +144% | +$2.55M | 0.02% | 671 |
|
|
2015
Q2 | $1.71M | Buy |
+58,329
| New | +$1.76M | 0.01% | 1022 |
|
|
2015
Q1 | – | Sell |
-36,927
| Closed | -$1.03M | – | 2469 |
|
|
2014
Q4 | $1.03M | Sell |
36,927
-5,056
| -12% | -$133K | 0.01% | 1306 |
|
|
2014
Q3 | $1.05M | Buy |
+41,983
| New | +$928K | 0.01% | 1243 |
|
Other funds holding CTLT
FCM
VAM
Metropolitan Life Insurance Company (MetLife)'s CTLT Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of CATALENT, INC. (CTLT) in Q2 2024, closing a stake of 7,289 shares — an estimated $411K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in CTLT in Q3 2014 and held it in 38 quarters. The position peaked at $16.3M in Q3 2017. 448 funds tracked by Wall St. Rank hold CTLT as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining CATALENT, INC. position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 7,289 CATALENT, INC. shares in Q2 2024, an estimated $411K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in CATALENT, INC. in Q3 2014 and held it in 38 quarters.
- Metropolitan Life Insurance Company (MetLife)'s CATALENT, INC. position peaked at $16.3M in Q3 2017.
- 448 funds tracked by Wall St. Rank held CATALENT, INC. as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.